Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Inovio's shares tumble 33% as COVID-19 vaccine trial is put on hold
07:16am, Monday, 28'th Sep 2020
Shares of Inovio Pharmaceuticals Inc. were halted in premarket trading on Monday before the company said the Phase 2/3 clinical trial for its COVID-19 vaccine candidate was in a "partial clinical hold
Is Inovio Worth Buying During the Market Correction?
07:36am, Saturday, 26'th Sep 2020
If you're into underdogs, you might want to add this pharmaceutical company to your portfolio.
Speculate on Inovio and Covid-19 Vaccine Developers
12:46pm, Friday, 25'th Sep 2020
After bottoming at $10 earlier this month, investor interest soared in the last week for INO stock and the company's DNA medicine.
The post Speculate on Inovio and Covid-19 Vaccine Developers appeared
Inovio Stock May Very Well Be the Long Shot Vaccine Gamble Worth Taking
08:10am, Thursday, 24'th Sep 2020
Inovio's DNA-based approach gives potential advantages to its Covid-19 vaccine candidate and adds fuel to the volatility of INO stock.
The post Inovio Stock May Very Well Be the Long Shot Vaccine Gam
3 Events Behind Inovio's Volatile Ride Wednesday
03:07pm, Wednesday, 23'rd Sep 2020
Inovio Pharmaceuticals Inc. shares were volatile Wednesday amid external developments and a presentation by CEO Joseph Kim at a health care conference.
Inovio Pharmaceuticals, Inc. (INO) President & CEO Joseph Kim Presents at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Transcript
Why Inovio Pharmaceuticals Stock Is Down Today
11:50am, Wednesday, 23'rd Sep 2020
Short-seller Citron Research strikes again.
Now Is the Perfect Time to Invest in Coronavirus Vaccine Stocks
07:03am, Wednesday, 23'rd Sep 2020
Today, investors are better prepared to choose potential winners.
DNA Vaccine Gives Inovio Pharmaceuticals Stock a Long Shelf Life
11:10am, Tuesday, 22'nd Sep 2020
INO stock traders may be skeptical about Inovio's main Covid-19 vaccine candidate, but the CEO made a convincing case to stay in the trade.
The post DNA Vaccine Gives Inovio Pharmaceuticals Stock a L
3 Critical Catalysts on the Way for Inovio
06:04am, Tuesday, 22'nd Sep 2020
With three important milestones just ahead, the biotech stock will likely soar or sink in the near future.
Inovio Defies Market-Wide Weakness: What's Behind The Rally?
03:35pm, Monday, 21'st Sep 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares have been seeing strong momentum ever since hitting a near-term low of $8.78 on Sept. 4.
Inovio Pharmaceuticals Stock Could See More Downside From $16
09:00am, Monday, 21'st Sep 2020
After a massive 2.5x rise since the March 23 lows of this year, at the current price of around $16 per share we believe Inovio Pharmaceuticals stock has run its course, and any significant upside from
Are the Gains Over for This Early Leader in the Coronavirus Vaccine Race?
08:25am, Saturday, 19'th Sep 2020
Investors came back to the biotech's shares early this week. But will the optimism stick?
The Compelling Science and the Harsh Risks Behind Inovio Pharmaceuticals
12:47pm, Friday, 18'th Sep 2020
Although vaccine plays are inherently risky, the recent robust rally in INO stock is backed by strong and compelling science.
The post The Compelling Science and the Harsh Risks Behind Inovio Pharmace
Why Inovio Stock Is Bouncing Back Today
11:49am, Friday, 18'th Sep 2020
No news is good news for the coronavirus-focused biotech.
